KABS Laboratories Inc.
$36,657,400.00 CAD
None of our seven automatic checks marked this record. What are the warning signs?
- Program The named fund or plan that the money comes from.
- SIF Stream 2 - Growth
- Recipient country
- Canada
- Fiscal year The government's budget year. It starts on April 1 and ends on March 31. For example, 2023-2024 is from April 2023 to March 2024.
- 2020-2021
- Agreement period The start date and the end date of the deal. The money can be paid at different times in this period.
- March 28, 2021 – July 2, 2050
- Reference
- ic:033-2020-2021-Q4-815813
Published purpose
The project aims to increase the company’s capacity for Good Manufacturing Practice (GMP) compliant bio-manufacturing in two separate factories of medium (new Val-des-Sources facility) and large capacity (existing St-Hubert plant) to produce biologics against COVID-19. The project’s work phase is scheduled to end on March 31, 2026.
In plain English AI-generated
Funding supports expansion of a biomanufacturing facility in St-Hubert, Quebec, and establishment of a new facility in Val-des-Sources, Quebec, to produce monoclonal antibody therapies and fill/pack them.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.